世界の禁煙ガム市場2020-2024

◆英語タイトル:Global Tobacco Alternative Gums Market 2020-2024
◆商品コード:IRTNTR44760
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年8月24日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、禁煙ガムの世界市場を調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別(2mgニコチンガム、4mgニコチンガム)分析、流通チャネル別(オフライン、オンライン)分析、顧客状況、地域別状況、企業状況、企業分析などの項目を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・禁煙ガムの世界市場規模:種類別(2mgニコチンガム、4mgニコチンガム)
・禁煙ガムの世界市場規模:流通チャネル別(オフライン、オンライン)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Tobacco Alternative Gums Market 2020-2024
Technavio has been monitoring the tobacco alternative gums market and it is poised to grow by $ 660.60 mn during 2020-2024, progressing at a CAGR of 6% during the forecast period. Our reports on tobacco alternative gums market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the demand for nicotine gum in smoking cessation therapy and increasing awareness about the harmful effects of cigarette smoking. In addition, the demand for nicotine gum in smoking cessation therapy is anticipated to boost the growth of the market as well.

The tobacco alternative gums market analysis includes type segment and geographical landscapes
Technavio’s tobacco alternative gums market is segmented as below:

By Type
• 2-mg nicotine gum
• 4-mg nicotine gum

By Geographical landscapes
• North America
• Europe
• APAC
• MEA
• South America

This study identifies rising prices of cigarettes as one of the prime reasons driving the tobacco alternative gums market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our tobacco alternative gums market covers the following areas:
• Tobacco alternative gums market sizing
• Tobacco alternative gums market forecast
• Tobacco alternative gums market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tobacco alternative gums market vendors that include Alchem International Pvt. Ltd., Cambrex Corp., Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, ITC Ltd., Johnson & Johnson, Novartis AG, Perrigo Co. Plc, and Takeda Pharmaceutical Co. Ltd. Also, the tobacco alternative gums market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/tobacco-alternative-gums-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Type
o Market segments
o Comparison by Type
o 2-mg nicotine gum – Market size and forecast 2019-2024
o 4-mg nicotine gum – Market size and forecast 2019-2024
o Market opportunity by Type
• Market Segmentation by Distribution Channel
o Offline
o Online
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o MEA – Market size and forecast 2019-2024
o South America – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers – Demand led growth
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Alchem International Pvt. Ltd.
o Cambrex Corp.
o Cipla Inc.
o Dr. Reddys Laboratories Ltd.
o GlaxoSmithKline Plc
o ITC Ltd.
o Johnson & Johnson
o Novartis AG
o Perrigo Co. Plc
o Takeda Pharmaceutical Co. Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: 2-mg nicotine gum – Market size and forecast 2019-2024 ($ million)
• 22: 2-mg nicotine gum – Year-over-year growth 2019-2024 (%)
• 23: 4-mg nicotine gum – Market size and forecast 2019-2024 ($ million)
• 24: 4-mg nicotine gum – Year-over-year growth 2019-2024 (%)
• 25: Customer landscape
• 26: Impact of drivers and challenges
• 27: Vendor landscape
• 28: Landscape disruption
• 29: Industry risks
• 30: Vendors covered
• 31: Market positioning of vendors
• 32: Alchem International Pvt. Ltd. – Overview
• 33: Alchem International Pvt. Ltd. – Product and service
• 34: Alchem International Pvt. Ltd. – Key offerings
• 35: Alchem International Pvt. Ltd. – Key customers
• 36: Alchem International Pvt. Ltd. – Segment focus
• 37: Cambrex Corp. – Overview
• 38: Cambrex Corp. – Product and service
• 39: Cambrex Corp. – Key offerings
• 40: Cambrex Corp. – Key customers
• 41: Cambrex Corp. – Segment focus
• 42: Cipla Inc. – Overview
• 43: Cipla Inc. – Business segments
• 44: Cipla Inc. – Key offerings
• 45: Cipla Inc. – Key customers
• 46: Cipla Inc. – Segment focus
• 47: Dr. Reddys Laboratories Ltd. – Overview
• 48: Dr. Reddys Laboratories Ltd. – Business segments
• 49: Dr. Reddys Laboratories Ltd. – Key offerings
• 50: Dr. Reddys Laboratories Ltd. – Key customers
• 51: Dr. Reddys Laboratories Ltd. – Segment focus
• 52: GlaxoSmithKline Plc – Overview
• 53: GlaxoSmithKline Plc – Business segments
• 54: GlaxoSmithKline Plc – Key offerings
• 55: GlaxoSmithKline Plc – Key customers
• 56: GlaxoSmithKline Plc – Segment focus
• 57: ITC Ltd. – Overview
• 58: ITC Ltd. – Business segments
• 59: ITC Ltd. – Key offerings
• 60: ITC Ltd. – Key customers
• 61: ITC Ltd. – Segment focus
• 62: Johnson & Johnson – Overview
• 63: Johnson & Johnson – Business segments
• 64: Johnson & Johnson – Key offerings
• 65: Johnson & Johnson – Key customers
• 66: Johnson & Johnson – Segment focus
• 67: Novartis AG – Overview
• 68: Novartis AG – Business segments
• 69: Novartis AG – Key offerings
• 70: Novartis AG – Key customers
• 71: Novartis AG – Segment focus
• 72: Perrigo Co. Plc – Overview
• 73: Perrigo Co. Plc – Business segments
• 74: Perrigo Co. Plc – Key offerings
• 75: Perrigo Co. Plc – Key customers
• 76: Perrigo Co. Plc – Segment focus
• 77: Takeda Pharmaceutical Co. Ltd. – Overview
• 78: Takeda Pharmaceutical Co. Ltd. – Product and service
• 79: Takeda Pharmaceutical Co. Ltd. – Key offerings
• 80: Takeda Pharmaceutical Co. Ltd. – Key customers
• 81: Takeda Pharmaceutical Co. Ltd. – Segment focus
• 82: Currency conversion rates for US$
• 83: Research Methodology
• 84: Validation techniques employed for market sizing
• 85: Information sources
• 86: List of abbreviations



【掲載企業】

Alchem International Pvt. Ltd., Cambrex Corp., Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, ITC Ltd., Johnson & Johnson, Novartis AG, Perrigo Co. Plc, Takeda Pharmaceutical Co. Ltd.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の禁煙ガム市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆